tl;dr
"Oncologist Samir Parekh and his colleagues at the Mount Sinai Icahn School of Medicine in New York wanted to change the treatment paradigm in multiple myeloma. So they developed a system that uses an algorithm to match up multiple myeloma patients with drugs that are already on the market to treat other cancers. They tried the resulting recommendations in a group of 21 patients with treatment-resistant multiple myeloma and got positive results in all but five—a response rate that’s so high Parekh believes the idea could be extended to many other cancers."The title makes it sound like what IBM aspired to do, but it's more of a statistical algorithm than "AI".